Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

Published:2001-04 Issue:8 Volume:27 Page:801-807
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Reynolds C,Ratanatharathorn V,Adams P,Braun T,Silver S,Ayash L,Carson E,Eisbruch A,Dawson LA,McDonagh K,Ferrara J,Uberti J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703006.pdf

Reference27 articles.

1. Cunningham D, Paz-Ares L, Gore ME et al. High-dose melphalan for multiple myeloma: long-term follow-up data J Clin Oncol 1994 12: 764–768

2. Barlogie B, Hall R, Zander A et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma Blood 1986 67: 1298–1301

3. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome New Engl J Med 1996 335: 91–97

4. Gahrton G . Treatment of multiple myeloma Lancet 1999 353: 85–86

5. Mehta J, Singhal S . Graft-versus-myeloma Bone Marrow Transplant 1998 22: 835–843

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit;Scientific Reports;2022-09-23

2. Acremonium Potronii Associated Pneumonia in an Allogeneic Stem Cell Transplantation Recipient;Gazi Medical Journal;2016-10

3. Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells;Molecular Oncology;2013-12-12

4. Immunotherapeutic approaches to treat multiple myeloma;Human Vaccines & Immunotherapeutics;2013-12-11

5. Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma;The Oncologist;2013-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3